Cargando…

Correction: Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients

Detalles Bibliográficos
Autores principales:	Hontecillas-Prieto, Lourdes, Garcia-Dominguez, Daniel J., Vaca, Diego Pascual, Garcia-Mejias, Rosa, Marcilla, David, Ramirez-Villar, Gema L., Saez, Carmen, de Álava, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610034/ https://www.ncbi.nlm.nih.gov/pubmed/28969102 http://dx.doi.org/10.18632/oncotarget.20708

Ejemplares similares

Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
por: Hontecillas-Prieto, Lourdes, et al.
Publicado: (2017)

HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients
por: Hontecillas-Prieto, Lourdes, et al.
Publicado: (2017)

Wilms’ Tumor Blastemal Stem Cells Dedifferentiate to Propagate the Tumor Bulk
por: Shukrun, Rachel, et al.
Publicado: (2014)

High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro
por: Wegert, Jenny, et al.
Publicado: (2019)

Two Origins of Blastemal Progenitors Define Blastemal Regeneration of Zebrafish Lower Jaw
por: Wang, Xuelong, et al.
Publicado: (2012)

Rare case of blastemal predominant adult Wilms’ tumor with skeletal metastasis case report and brief review of literature
por: Patnayak, Rashmi, et al.
Publicado: (2012)

Characterization of Continuous Transcriptional Heterogeneity in High-Risk Blastemal-Type Wilms’ Tumors Using Unsupervised Machine Learning
por: Trink, Yaron, et al.
Publicado: (2023)

Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset
por: Maschietto, M, et al.
Publicado: (2011)

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
por: Hontecillas-Prieto, Lourdes, et al.
Publicado: (2020)

The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
por: García-Domínguez, Daniel Jose, et al.
Publicado: (2018)

Regulatory T cells regulate blastemal proliferation during zebrafish caudal fin regeneration
por: Hui, Subhra P., et al.
Publicado: (2022)

Stratification of Wilms tumor by genetic and epigenetic analysis
por: Scott, Richard H., et al.
Publicado: (2012)

An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis
por: García-Domínguez, Daniel J., et al.
Publicado: (2020)

Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
por: Sánchez-Molina, Sara, et al.
Publicado: (2022)

Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China
por: Sun, Yanni, et al.
Publicado: (2015)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
por: Wolfensberger, Aline, et al.
Publicado: (2019)

Multidrug resistance (mdr) genes in human cancer.
por: Nooter, K., et al.
Publicado: (1991)

High Cyclin E Staining Index in Blastemal, Stromal or Epithelial Cells Is Correlated with Tumor Aggressiveness in Patients with Nephroblastoma
por: Berrebi, Dominique, et al.
Publicado: (2008)

Wilms' Tumour
por: Pearson, D.
Publicado: (1976)

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925
por: Yang, X, et al.
Publicado: (2014)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
por: Ali, Monadil H., et al.
Publicado: (2019)

TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia
por: Maschietto, Mariana, et al.
Publicado: (2014)

Gene expression in bryozoan larvae suggest a fundamental importance of pre-patterned blastemic cells in the bryozoan life-cycle
por: Fuchs, Judith, et al.
Publicado: (2011)

Regulation and expression of multidrug resistance (MDR) transcripts in the intestinal epithelium
por: Li, M, et al.
Publicado: (1999)

Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
por: Wang, Jinglu, et al.
Publicado: (2017)

Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
por: Catalano, Alessia, et al.
Publicado: (2022)

Both Epimutations and Chromosome Aberrations Affect Multiple Imprinted Loci in Aggressive Wilms Tumors
por: Pignata, Laura, et al.
Publicado: (2020)

Wilms' tumour and parental age: a report from the National Wilms' Tumour Study.
por: Olson, J. M., et al.
Publicado: (1993)

Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents
por: Feng, Senling, et al.
Publicado: (2020)

Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies.
por: Barrand, M. A., et al.
Publicado: (1992)

Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
por: Muñoz Velasco, Raúl, et al.
Publicado: (2022)

The stem and roots of Wilms' tumours
por: Hohenstein, Peter
Publicado: (2013)

Antenatally Diagnosed Wilms’ Tumour
por: Sarin, YK, et al.
Publicado: (2014)

Molecular Biology of Wilm's Tumour
por: Shaw, A. P. W., et al.
Publicado: (1988)

Wilms’ tumour and chemotherapeutic access
por: Yasri, Sora, et al.
Publicado: (2015)

Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids
por: Limtrakul, Pornngarm, et al.
Publicado: (2004)

Functional Evidence of Multidrug Resistance Transporters (MDR) in Rodent Olfactory Epithelium
por: Molinas, Adrien, et al.
Publicado: (2012)

Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer
por: Reis, Mariana Alves, et al.
Publicado: (2020)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
por: Sabur, Natasha F., et al.
Publicado: (2021)

Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii
por: Kumar, Sunil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b8bjf2vu3unmk7144k67ed7l6k